Biotest AG - Company Profile
Powered by
All the data and insights you need on Biotest AG in one report.
- Save hours of research time and resources with
our up-to-date Biotest AG Strategy Report
- Understand Biotest AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Biotest AG (Biotest), a subsidiary of Grifols SA, provides pharmaceutical and biotherapeutic drugs. It develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products include clotting factors, immunoglobulins, albumin and monoclonal antibodies in clinical development. The company specializes in the areas of clinical immunology, haematology and intensive care medicine. Biotest distributes its products through local marketing partners and distributors in Europe, North America, South America, Asia, the Middle East, and Africa. It has subsidiaries and sales companies in Austria, Switzerland, France, Great Britain, Italy, Hungary and Spain and Brazil. Biotest is headquartered in Dreieich, Hessen, Germany.
Biotest AG premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Pharmaceuticals: | Haemonine |
Plasma Proteins | Haemoctin |
Immunoglobins | Cytotect |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Corporate Changes/Expansions | In January, the company opened its 11th plasma collection center in Cologne, Germany. |
2023 | Others | In December, the company expanded its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP). |
2023 | Contracts/Agreements | In April, the company strengthened its partnership with Grifols S.A. in the field of research & development, manufacturing, operations as well as sales and distribution. |
Competitor Comparison
Key Parameters | Biotest AG | Takeda Pharmaceutical Co Ltd | Celltrion Inc | Halozyme Therapeutics Inc | Stratec SE |
---|---|---|---|---|---|
Headquarters | Germany | Japan | South Korea | United States of America | Germany |
City | Dreieich | Chuo-Ku | Incheon | San Diego | Birkenfeld |
State/Province | Hessen | Tokyo | - | California | Rheinland-Pfalz |
No. of Employees | 2,426 | 49,095 | 1,074 | 373 | 1,522 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Michael Ramroth, Ph.D. | Chief Executive Officer | Senior Management | - | 62 |
Ainhoa Mendizabal | Chief Financial Officer | Senior Management | 2023 | 51 |
Peter Janssen | Chief Operating Officer | Senior Management | 2022 | 57 |
Jorg Schuttrumpf | Chief Scientific Officer | Senior Management | 2022 | 49 |
Bernhard Ehmer | Chairman | Non Executive Board | 2022 | 68 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward